nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Central Nervous System Stimulation—Methamphetamine—obesity	0.205	1	CiPCiCtD
Amphetamine—CARTPT—obesity	0.0882	0.818	CbGaD
Amphetamine—narcolepsy—Methamphetamine—obesity	0.0693	0.533	CpDpCtD
Amphetamine—Diethylpropion—obesity	0.0507	0.243	CrCtD
Amphetamine—Phenylpropanolamine—obesity	0.0492	0.236	CrCtD
Amphetamine—Phentermine—obesity	0.0418	0.201	CrCtD
Amphetamine—Methamphetamine—obesity	0.0373	0.179	CrCtD
Amphetamine—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.0304	0.234	CpDpCtD
Amphetamine—attention deficit hyperactivity disorder—Bupropion—obesity	0.0304	0.234	CpDpCtD
Amphetamine—Benzphetamine—obesity	0.0296	0.142	CrCtD
Amphetamine—TAAR1—Methamphetamine—obesity	0.0222	0.149	CbGbCtD
Amphetamine—SLC18A2—Benzphetamine—obesity	0.0108	0.0724	CbGbCtD
Amphetamine—SLC6A4—obesity	0.00981	0.091	CbGaD
Amphetamine—DRD2—obesity	0.00975	0.0905	CbGaD
Amphetamine—SLC18A2—Methamphetamine—obesity	0.00863	0.0579	CbGbCtD
Amphetamine—MAOB—Phentermine—obesity	0.00765	0.0513	CbGbCtD
Amphetamine—SLC6A3—Diethylpropion—obesity	0.00709	0.0476	CbGbCtD
Amphetamine—MAOB—Methamphetamine—obesity	0.00611	0.041	CbGbCtD
Amphetamine—Tranylcypromine—Phendimetrazine—obesity	0.006	0.0428	CrCrCtD
Amphetamine—SLC6A3—Phendimetrazine—obesity	0.00537	0.036	CbGbCtD
Amphetamine—SLC6A3—Sibutramine—obesity	0.00537	0.036	CbGbCtD
Amphetamine—SLC6A2—Diethylpropion—obesity	0.00519	0.0348	CbGbCtD
Amphetamine—SLC22A3—Methamphetamine—obesity	0.00481	0.0323	CbGbCtD
Amphetamine—SLC6A4—Sibutramine—obesity	0.0047	0.0315	CbGbCtD
Amphetamine—SLC6A3—Phentermine—obesity	0.00407	0.0273	CbGbCtD
Amphetamine—SLC6A3—Benzphetamine—obesity	0.00407	0.0273	CbGbCtD
Amphetamine—SLC6A2—Phendimetrazine—obesity	0.00393	0.0264	CbGbCtD
Amphetamine—SLC6A2—Sibutramine—obesity	0.00393	0.0264	CbGbCtD
Amphetamine—SLC6A3—Phenylpropanolamine—obesity	0.00388	0.0261	CbGbCtD
Amphetamine—SLC22A3—Cimetidine—obesity	0.00375	0.0252	CbGbCtD
Amphetamine—Tranylcypromine—Phenylpropanolamine—obesity	0.00364	0.0259	CrCrCtD
Amphetamine—SLC6A4—Phentermine—obesity	0.00356	0.0239	CbGbCtD
Amphetamine—SLC6A3—Bupropion—obesity	0.00346	0.0232	CbGbCtD
Amphetamine—SLC6A3—Methamphetamine—obesity	0.00325	0.0218	CbGbCtD
Amphetamine—Amfecloral—Phentermine—obesity	0.00309	0.022	CrCrCtD
Amphetamine—Tranylcypromine—Phentermine—obesity	0.00309	0.022	CrCrCtD
Amphetamine—SLC22A5—Methamphetamine—obesity	0.00298	0.02	CbGbCtD
Amphetamine—SLC6A2—Benzphetamine—obesity	0.00298	0.02	CbGbCtD
Amphetamine—SLC6A2—Phentermine—obesity	0.00298	0.02	CbGbCtD
Amphetamine—Phenformin—Phentermine—obesity	0.0029	0.0207	CrCrCtD
Amphetamine—Pseudoephedrine—Phenylpropanolamine—obesity	0.00289	0.0206	CrCrCtD
Amphetamine—Ephedrine—Phenylpropanolamine—obesity	0.00289	0.0206	CrCrCtD
Amphetamine—SLC6A4—Methamphetamine—obesity	0.00285	0.0191	CbGbCtD
Amphetamine—SLC6A2—Phenylpropanolamine—obesity	0.00284	0.0191	CbGbCtD
Amphetamine—Selegiline—Diethylpropion—obesity	0.00283	0.0202	CrCrCtD
Amphetamine—Amfecloral—Methamphetamine—obesity	0.00276	0.0197	CrCrCtD
Amphetamine—Phenylpropanolamine—Phentermine—obesity	0.00273	0.0195	CrCrCtD
Amphetamine—Tolazoline—Phentermine—obesity	0.00259	0.0184	CrCrCtD
Amphetamine—Phenformin—Methamphetamine—obesity	0.00258	0.0184	CrCrCtD
Amphetamine—Lisdexamfetamine—Methamphetamine—obesity	0.00258	0.0184	CrCrCtD
Amphetamine—Diethylpropion—Methamphetamine—obesity	0.00258	0.0184	CrCrCtD
Amphetamine—SLC6A2—Bupropion—obesity	0.00253	0.017	CbGbCtD
Amphetamine—Phenol—Phenylpropanolamine—obesity	0.00252	0.018	CrCrCtD
Amphetamine—Ephedrine—Phentermine—obesity	0.00246	0.0175	CrCrCtD
Amphetamine—Lacosamide—Phentermine—obesity	0.00246	0.0175	CrCrCtD
Amphetamine—Pseudoephedrine—Phentermine—obesity	0.00246	0.0175	CrCrCtD
Amphetamine—Phenylpropanolamine—Methamphetamine—obesity	0.00244	0.0174	CrCrCtD
Amphetamine—Phenelzine—Phenylpropanolamine—obesity	0.00242	0.0172	CrCrCtD
Amphetamine—CYP2A6—Bupropion—obesity	0.00241	0.0162	CbGbCtD
Amphetamine—SLC6A2—Methamphetamine—obesity	0.00238	0.016	CbGbCtD
Amphetamine—Selegiline—Phentermine—obesity	0.00234	0.0167	CrCrCtD
Amphetamine—SLC22A5—Cimetidine—obesity	0.00233	0.0156	CbGbCtD
Amphetamine—Phentermine—Phenylpropanolamine—obesity	0.00232	0.0166	CrCrCtD
Amphetamine—Nateglinide—Methamphetamine—obesity	0.0023	0.0164	CrCrCtD
Amphetamine—Tolazoline—Methamphetamine—obesity	0.0023	0.0164	CrCrCtD
Amphetamine—Fenproporex—Phentermine—obesity	0.00223	0.0159	CrCrCtD
Amphetamine—Pargyline—Phentermine—obesity	0.00223	0.0159	CrCrCtD
Amphetamine—Bethanidine—Phentermine—obesity	0.00223	0.0159	CrCrCtD
Amphetamine—Ephedrine—Methamphetamine—obesity	0.00219	0.0156	CrCrCtD
Amphetamine—Aspartame—Methamphetamine—obesity	0.00219	0.0156	CrCrCtD
Amphetamine—Lacosamide—Methamphetamine—obesity	0.00219	0.0156	CrCrCtD
Amphetamine—Pseudoephedrine—Methamphetamine—obesity	0.00219	0.0156	CrCrCtD
Amphetamine—Benzyl alcohol—Phenylpropanolamine—obesity	0.00216	0.0154	CrCrCtD
Amphetamine—Mephentermine—Phentermine—obesity	0.00214	0.0153	CrCrCtD
Amphetamine—Phenol—Phentermine—obesity	0.00214	0.0153	CrCrCtD
Amphetamine—Selegiline—Methamphetamine—obesity	0.00209	0.0149	CrCrCtD
Amphetamine—Phenelzine—Phentermine—obesity	0.00205	0.0147	CrCrCtD
Amphetamine—Bethanidine—Methamphetamine—obesity	0.00199	0.0142	CrCrCtD
Amphetamine—Fenproporex—Methamphetamine—obesity	0.00199	0.0142	CrCrCtD
Amphetamine—Pargyline—Methamphetamine—obesity	0.00199	0.0142	CrCrCtD
Amphetamine—Dextroamphetamine—Diethylpropion—obesity	0.00196	0.014	CrCrCtD
Amphetamine—Mephentermine—Methamphetamine—obesity	0.00191	0.0136	CrCrCtD
Amphetamine—Phenol—Methamphetamine—obesity	0.00191	0.0136	CrCrCtD
Amphetamine—Methamphetamine—Diethylpropion—obesity	0.0019	0.0136	CrCrCtD
Amphetamine—Dextroamphetamine—Phenylpropanolamine—obesity	0.0019	0.0136	CrCrCtD
Amphetamine—Methamphetamine—Phenylpropanolamine—obesity	0.00185	0.0132	CrCrCtD
Amphetamine—Benzyl alcohol—Phentermine—obesity	0.00184	0.0131	CrCrCtD
Amphetamine—Phenelzine—Methamphetamine—obesity	0.00183	0.0131	CrCrCtD
Amphetamine—Phentermine—Methamphetamine—obesity	0.00176	0.0126	CrCrCtD
Amphetamine—Phenacemide—Phentermine—obesity	0.00167	0.0119	CrCrCtD
Amphetamine—Selegiline—Benzphetamine—obesity	0.00165	0.0118	CrCrCtD
Amphetamine—Benzyl alcohol—Methamphetamine—obesity	0.00164	0.0117	CrCrCtD
Amphetamine—Dextroamphetamine—Phentermine—obesity	0.00162	0.0115	CrCrCtD
Amphetamine—Fenproporex—Benzphetamine—obesity	0.00158	0.0113	CrCrCtD
Amphetamine—Pargyline—Benzphetamine—obesity	0.00158	0.0113	CrCrCtD
Amphetamine—Monobenzone—Benzphetamine—obesity	0.00158	0.0113	CrCrCtD
Amphetamine—Methamphetamine—Phentermine—obesity	0.00157	0.0112	CrCrCtD
Amphetamine—L-Phenylalanine—Diethylpropion—obesity	0.00149	0.0106	CrCrCtD
Amphetamine—Phenacemide—Methamphetamine—obesity	0.00148	0.0106	CrCrCtD
Amphetamine—L-Phenylalanine—Phenylpropanolamine—obesity	0.00145	0.0103	CrCrCtD
Amphetamine—Dextroamphetamine—Methamphetamine—obesity	0.00144	0.0103	CrCrCtD
Amphetamine—L-Phenylalanine—Phentermine—obesity	0.00123	0.00877	CrCrCtD
Amphetamine—Dextroamphetamine—Benzphetamine—obesity	0.00114	0.00815	CrCrCtD
Amphetamine—Methamphetamine—Benzphetamine—obesity	0.00111	0.00791	CrCrCtD
Amphetamine—L-Phenylalanine—Methamphetamine—obesity	0.0011	0.00781	CrCrCtD
Amphetamine—CYP2D6—Phentermine—obesity	0.000893	0.00599	CbGbCtD
Amphetamine—Benzphetamine—Methamphetamine—obesity	0.00088	0.00627	CrCrCtD
Amphetamine—CARTPT—hindbrain—obesity	0.000855	0.11	CbGeAlD
Amphetamine—CYP2D6—Bupropion—obesity	0.000759	0.0051	CbGbCtD
Amphetamine—CYP2D6—Methamphetamine—obesity	0.000714	0.00479	CbGbCtD
Amphetamine—SLC6A2—sympathetic nervous system—obesity	0.000626	0.0804	CbGeAlD
Amphetamine—CYP2D6—Cimetidine—obesity	0.000557	0.00374	CbGbCtD
Amphetamine—TAAR1—respiratory system—obesity	0.000522	0.0671	CbGeAlD
Amphetamine—CARTPT—adrenal cortex—obesity	0.000438	0.0563	CbGeAlD
Amphetamine—SLC6A2—autonomic nervous system—obesity	0.000421	0.054	CbGeAlD
Amphetamine—CARTPT—pituitary gland—obesity	0.000354	0.0455	CbGeAlD
Amphetamine—CARTPT—adrenal gland—obesity	0.000316	0.0406	CbGeAlD
Amphetamine—CARTPT—endocrine gland—obesity	0.000274	0.0352	CbGeAlD
Amphetamine—SLC6A3—hindbrain—obesity	0.00022	0.0282	CbGeAlD
Amphetamine—SLC6A4—hindbrain—obesity	0.000201	0.0259	CbGeAlD
Amphetamine—MAOB—hindbrain—obesity	0.000191	0.0246	CbGeAlD
Amphetamine—DRD2—hindbrain—obesity	0.000162	0.0207	CbGeAlD
Amphetamine—SLC6A3—respiratory system—obesity	0.000134	0.0172	CbGeAlD
Amphetamine—Phenelzine—GPT—obesity	0.000126	0.179	CrCbGaD
Amphetamine—SLC6A4—respiratory system—obesity	0.000123	0.0158	CbGeAlD
Amphetamine—SLC18A2—adipose tissue—obesity	0.00012	0.0154	CbGeAlD
Amphetamine—MAOB—respiratory system—obesity	0.000117	0.015	CbGeAlD
Amphetamine—SLC18A2—digestive system—obesity	0.000113	0.0145	CbGeAlD
Amphetamine—SLC6A2—respiratory system—obesity	0.000108	0.0139	CbGeAlD
Amphetamine—SLC18A2—adrenal gland—obesity	0.000107	0.0138	CbGeAlD
Amphetamine—CYP2A6—adipose tissue—obesity	0.000107	0.0137	CbGeAlD
Amphetamine—Lacosamide—CA3—obesity	0.000105	0.149	CrCbGaD
Amphetamine—DRD2—respiratory system—obesity	9.86e-05	0.0127	CbGeAlD
Amphetamine—MAOB—adrenal cortex—obesity	9.81e-05	0.0126	CbGeAlD
Amphetamine—CYP2D6—hindbrain—obesity	9.7e-05	0.0125	CbGeAlD
Amphetamine—SLC18A2—endocrine gland—obesity	9.32e-05	0.012	CbGeAlD
Amphetamine—SLC22A5—respiratory system—obesity	9.18e-05	0.0118	CbGeAlD
Amphetamine—MAOB—cardiovascular system—obesity	8.95e-05	0.0115	CbGeAlD
Amphetamine—SLC22A3—adipose tissue—obesity	8.53e-05	0.011	CbGeAlD
Amphetamine—SLC18A2—liver—obesity	8.4e-05	0.0108	CbGeAlD
Amphetamine—Aspartame—TRPV1—obesity	8.29e-05	0.117	CrCbGaD
Amphetamine—Phenelzine—AOC3—obesity	8.13e-05	0.115	CrCbGaD
Amphetamine—MAOB—pituitary gland—obesity	7.93e-05	0.0102	CbGeAlD
Amphetamine—MAOB—adipose tissue—obesity	7.89e-05	0.0101	CbGeAlD
Amphetamine—SLC6A4—digestive system—obesity	7.82e-05	0.01	CbGeAlD
Amphetamine—SLC22A5—adrenal cortex—obesity	7.71e-05	0.0099	CbGeAlD
Amphetamine—SLC22A3—adrenal gland—obesity	7.65e-05	0.00983	CbGeAlD
Amphetamine—CYP2A6—liver—obesity	7.5e-05	0.00964	CbGeAlD
Amphetamine—MAOB—digestive system—obesity	7.43e-05	0.00955	CbGeAlD
Amphetamine—MAOB—adrenal gland—obesity	7.08e-05	0.0091	CbGeAlD
Amphetamine—DRD2—pituitary gland—obesity	6.69e-05	0.00859	CbGeAlD
Amphetamine—SLC22A3—endocrine gland—obesity	6.64e-05	0.00852	CbGeAlD
Amphetamine—SLC6A2—adrenal gland—obesity	6.56e-05	0.00842	CbGeAlD
Amphetamine—SLC6A4—endocrine gland—obesity	6.46e-05	0.0083	CbGeAlD
Amphetamine—SLC22A5—pituitary gland—obesity	6.23e-05	0.008	CbGeAlD
Amphetamine—SLC22A5—adipose tissue—obesity	6.2e-05	0.00797	CbGeAlD
Amphetamine—MAOB—endocrine gland—obesity	6.14e-05	0.00789	CbGeAlD
Amphetamine—SLC22A3—liver—obesity	5.98e-05	0.00769	CbGeAlD
Amphetamine—SLC22A5—digestive system—obesity	5.84e-05	0.0075	CbGeAlD
Amphetamine—SLC6A2—endocrine gland—obesity	5.69e-05	0.00731	CbGeAlD
Amphetamine—SLC22A5—adrenal gland—obesity	5.56e-05	0.00715	CbGeAlD
Amphetamine—MAOB—liver—obesity	5.54e-05	0.00711	CbGeAlD
Amphetamine—Constipation—Phenylpropanolamine—obesity	5.46e-05	0.00174	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Sibutramine—obesity	5.45e-05	0.00174	CcSEcCtD
Amphetamine—Dizziness—Benzphetamine—obesity	5.42e-05	0.00173	CcSEcCtD
Amphetamine—Dry mouth—Diethylpropion—obesity	5.42e-05	0.00173	CcSEcCtD
Amphetamine—Affect lability—Sibutramine—obesity	5.41e-05	0.00173	CcSEcCtD
Amphetamine—Dyspepsia—Phentermine—obesity	5.38e-05	0.00171	CcSEcCtD
Amphetamine—Psychotic disorder—Sibutramine—obesity	5.37e-05	0.00171	CcSEcCtD
Amphetamine—Headache—Methamphetamine—obesity	5.33e-05	0.0017	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Phentermine—obesity	5.27e-05	0.00168	CcSEcCtD
Amphetamine—Fatigue—Phentermine—obesity	5.27e-05	0.00168	CcSEcCtD
Amphetamine—Anxiety—Cimetidine—obesity	5.25e-05	0.00168	CcSEcCtD
Amphetamine—Constipation—Phentermine—obesity	5.22e-05	0.00167	CcSEcCtD
Amphetamine—Injury—Bupropion—obesity	5.21e-05	0.00166	CcSEcCtD
Amphetamine—Mood swings—Sibutramine—obesity	5.21e-05	0.00166	CcSEcCtD
Amphetamine—Abdominal pain upper—Orlistat—obesity	5.19e-05	0.00165	CcSEcCtD
Amphetamine—Tachycardia—Diethylpropion—obesity	5.19e-05	0.00165	CcSEcCtD
Amphetamine—DRD2—endocrine gland—obesity	5.18e-05	0.00666	CbGeAlD
Amphetamine—Libido decreased—Bupropion—obesity	5.17e-05	0.00165	CcSEcCtD
Amphetamine—Hyperhidrosis—Diethylpropion—obesity	5.14e-05	0.00164	CcSEcCtD
Amphetamine—Headache—Benzphetamine—obesity	5.13e-05	0.00164	CcSEcCtD
Amphetamine—Diarrhoea—Phendimetrazine—obesity	5.11e-05	0.00163	CcSEcCtD
Amphetamine—Anaphylactic shock—Cimetidine—obesity	5.06e-05	0.00161	CcSEcCtD
Amphetamine—Dizziness—Phendimetrazine—obesity	4.94e-05	0.00158	CcSEcCtD
Amphetamine—Tachycardia—Cimetidine—obesity	4.93e-05	0.00157	CcSEcCtD
Amphetamine—Cerebrovascular accident—Bupropion—obesity	4.89e-05	0.00156	CcSEcCtD
Amphetamine—Speech disorder—Topiramate—obesity	4.89e-05	0.00156	CcSEcCtD
Amphetamine—Nausea—Benzphetamine—obesity	4.87e-05	0.00155	CcSEcCtD
Amphetamine—Urticaria—Phentermine—obesity	4.85e-05	0.00155	CcSEcCtD
Amphetamine—Abdominal pain—Phentermine—obesity	4.83e-05	0.00154	CcSEcCtD
Amphetamine—Insomnia—Diethylpropion—obesity	4.81e-05	0.00153	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Bupropion—obesity	4.75e-05	0.00152	CcSEcCtD
Amphetamine—Dyspnoea—Diethylpropion—obesity	4.74e-05	0.00151	CcSEcCtD
Amphetamine—Somnolence—Diethylpropion—obesity	4.72e-05	0.00151	CcSEcCtD
Amphetamine—Affect lability—Bupropion—obesity	4.72e-05	0.0015	CcSEcCtD
Amphetamine—Hypersensitivity—Phenylpropanolamine—obesity	4.7e-05	0.0015	CcSEcCtD
Amphetamine—Headache—Phendimetrazine—obesity	4.68e-05	0.00149	CcSEcCtD
Amphetamine—Psychotic disorder—Bupropion—obesity	4.68e-05	0.00149	CcSEcCtD
Amphetamine—Dyspepsia—Diethylpropion—obesity	4.68e-05	0.00149	CcSEcCtD
Amphetamine—Viral infection—Topiramate—obesity	4.66e-05	0.00148	CcSEcCtD
Amphetamine—Dysmenorrhoea—Topiramate—obesity	4.62e-05	0.00147	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Diethylpropion—obesity	4.59e-05	0.00146	CcSEcCtD
Amphetamine—Irritability—Bupropion—obesity	4.57e-05	0.00146	CcSEcCtD
Amphetamine—Constipation—Diethylpropion—obesity	4.54e-05	0.00145	CcSEcCtD
Amphetamine—Mood swings—Bupropion—obesity	4.54e-05	0.00145	CcSEcCtD
Amphetamine—Somnolence—Cimetidine—obesity	4.49e-05	0.00143	CcSEcCtD
Amphetamine—Dyskinesia—Topiramate—obesity	4.47e-05	0.00143	CcSEcCtD
Amphetamine—Nausea—Phendimetrazine—obesity	4.44e-05	0.00142	CcSEcCtD
Amphetamine—Asthenia—Phentermine—obesity	4.38e-05	0.0014	CcSEcCtD
Amphetamine—Abdominal pain upper—Bupropion—obesity	4.38e-05	0.0014	CcSEcCtD
Amphetamine—Erectile dysfunction—Sibutramine—obesity	4.37e-05	0.0014	CcSEcCtD
Amphetamine—Depression—Orlistat—obesity	4.36e-05	0.00139	CcSEcCtD
Amphetamine—Fatigue—Cimetidine—obesity	4.36e-05	0.00139	CcSEcCtD
Amphetamine—SLC22A5—liver—obesity	4.35e-05	0.00559	CbGeAlD
Amphetamine—Photosensitivity reaction—Sibutramine—obesity	4.34e-05	0.00138	CcSEcCtD
Amphetamine—Constipation—Cimetidine—obesity	4.32e-05	0.00138	CcSEcCtD
Amphetamine—Muscle twitching—Topiramate—obesity	4.28e-05	0.00137	CcSEcCtD
Amphetamine—Urinary tract infection—Orlistat—obesity	4.25e-05	0.00136	CcSEcCtD
Amphetamine—Depression—Sibutramine—obesity	4.22e-05	0.00135	CcSEcCtD
Amphetamine—Urticaria—Diethylpropion—obesity	4.22e-05	0.00135	CcSEcCtD
Amphetamine—Dizziness—Phenylpropanolamine—obesity	4.22e-05	0.00135	CcSEcCtD
Amphetamine—Diarrhoea—Phentermine—obesity	4.18e-05	0.00133	CcSEcCtD
Amphetamine—Acute coronary syndrome—Sibutramine—obesity	4.17e-05	0.00133	CcSEcCtD
Amphetamine—Myocardial infarction—Sibutramine—obesity	4.15e-05	0.00132	CcSEcCtD
Amphetamine—Urinary tract infection—Sibutramine—obesity	4.12e-05	0.00131	CcSEcCtD
Amphetamine—Sweating—Sibutramine—obesity	4.06e-05	0.00129	CcSEcCtD
Amphetamine—Vomiting—Phenylpropanolamine—obesity	4.06e-05	0.00129	CcSEcCtD
Amphetamine—Dizziness—Phentermine—obesity	4.04e-05	0.00129	CcSEcCtD
Amphetamine—Rash—Phenylpropanolamine—obesity	4.02e-05	0.00128	CcSEcCtD
Amphetamine—Dermatitis—Phenylpropanolamine—obesity	4.02e-05	0.00128	CcSEcCtD
Amphetamine—Body temperature increased—Cimetidine—obesity	4e-05	0.00127	CcSEcCtD
Amphetamine—Vomiting—Phentermine—obesity	3.88e-05	0.00124	CcSEcCtD
Amphetamine—Rash—Phentermine—obesity	3.85e-05	0.00123	CcSEcCtD
Amphetamine—Dermatitis—Phentermine—obesity	3.85e-05	0.00123	CcSEcCtD
Amphetamine—Headache—Phentermine—obesity	3.83e-05	0.00122	CcSEcCtD
Amphetamine—Erectile dysfunction—Bupropion—obesity	3.81e-05	0.00122	CcSEcCtD
Amphetamine—Nausea—Phenylpropanolamine—obesity	3.79e-05	0.00121	CcSEcCtD
Amphetamine—Photosensitivity reaction—Bupropion—obesity	3.78e-05	0.00121	CcSEcCtD
Amphetamine—CYP2D6—digestive system—obesity	3.77e-05	0.00484	CbGeAlD
Amphetamine—Weight decreased—Bupropion—obesity	3.75e-05	0.00119	CcSEcCtD
Amphetamine—Hypersensitivity—Cimetidine—obesity	3.72e-05	0.00119	CcSEcCtD
Amphetamine—Phenformin—SLC22A1—obesity	3.69e-05	0.0523	CrCbGaD
Amphetamine—Stevens-Johnson syndrome—Bupropion—obesity	3.66e-05	0.00117	CcSEcCtD
Amphetamine—Acute coronary syndrome—Bupropion—obesity	3.64e-05	0.00116	CcSEcCtD
Amphetamine—Diarrhoea—Diethylpropion—obesity	3.64e-05	0.00116	CcSEcCtD
Amphetamine—Nausea—Phentermine—obesity	3.63e-05	0.00116	CcSEcCtD
Amphetamine—Asthenia—Cimetidine—obesity	3.63e-05	0.00116	CcSEcCtD
Amphetamine—Myocardial infarction—Bupropion—obesity	3.62e-05	0.00115	CcSEcCtD
Amphetamine—Euphoric mood—Topiramate—obesity	3.61e-05	0.00115	CcSEcCtD
Amphetamine—Urinary tract infection—Bupropion—obesity	3.59e-05	0.00114	CcSEcCtD
Amphetamine—Sweating—Bupropion—obesity	3.54e-05	0.00113	CcSEcCtD
Amphetamine—Dizziness—Diethylpropion—obesity	3.51e-05	0.00112	CcSEcCtD
Amphetamine—Diarrhoea—Cimetidine—obesity	3.46e-05	0.0011	CcSEcCtD
Amphetamine—Vomiting—Diethylpropion—obesity	3.38e-05	0.00108	CcSEcCtD
Amphetamine—Rash—Diethylpropion—obesity	3.35e-05	0.00107	CcSEcCtD
Amphetamine—Dermatitis—Diethylpropion—obesity	3.35e-05	0.00107	CcSEcCtD
Amphetamine—Dizziness—Cimetidine—obesity	3.34e-05	0.00107	CcSEcCtD
Amphetamine—Headache—Diethylpropion—obesity	3.33e-05	0.00106	CcSEcCtD
Amphetamine—Libido decreased—Topiramate—obesity	3.29e-05	0.00105	CcSEcCtD
Amphetamine—Tension—Sibutramine—obesity	3.25e-05	0.00104	CcSEcCtD
Amphetamine—Nervousness—Sibutramine—obesity	3.21e-05	0.00103	CcSEcCtD
Amphetamine—Vomiting—Cimetidine—obesity	3.21e-05	0.00103	CcSEcCtD
Amphetamine—Rash—Cimetidine—obesity	3.19e-05	0.00102	CcSEcCtD
Amphetamine—Dermatitis—Cimetidine—obesity	3.18e-05	0.00102	CcSEcCtD
Amphetamine—Headache—Cimetidine—obesity	3.17e-05	0.00101	CcSEcCtD
Amphetamine—Nausea—Diethylpropion—obesity	3.16e-05	0.00101	CcSEcCtD
Amphetamine—Erythema multiforme—Bupropion—obesity	3.13e-05	0.000999	CcSEcCtD
Amphetamine—Angioedema—Orlistat—obesity	3.12e-05	0.000997	CcSEcCtD
Amphetamine—CYP2D6—endocrine gland—obesity	3.11e-05	0.004	CbGeAlD
Amphetamine—Tremor—Sibutramine—obesity	3.1e-05	0.000989	CcSEcCtD
Amphetamine—Agitation—Sibutramine—obesity	3.04e-05	0.00097	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Topiramate—obesity	3.03e-05	0.000966	CcSEcCtD
Amphetamine—Angioedema—Sibutramine—obesity	3.02e-05	0.000964	CcSEcCtD
Amphetamine—Palpitations—Orlistat—obesity	3.02e-05	0.000964	CcSEcCtD
Amphetamine—Affect lability—Topiramate—obesity	3e-05	0.000958	CcSEcCtD
Amphetamine—Nausea—Cimetidine—obesity	3e-05	0.000958	CcSEcCtD
Amphetamine—Psychotic disorder—Topiramate—obesity	2.98e-05	0.000951	CcSEcCtD
Amphetamine—Convulsion—Orlistat—obesity	2.96e-05	0.000945	CcSEcCtD
Amphetamine—Palpitations—Sibutramine—obesity	2.92e-05	0.000933	CcSEcCtD
Amphetamine—Irritability—Topiramate—obesity	2.91e-05	0.000929	CcSEcCtD
Amphetamine—Chest pain—Orlistat—obesity	2.91e-05	0.000929	CcSEcCtD
Amphetamine—Anxiety—Orlistat—obesity	2.9e-05	0.000925	CcSEcCtD
Amphetamine—Mood swings—Topiramate—obesity	2.89e-05	0.000922	CcSEcCtD
Amphetamine—Convulsion—Sibutramine—obesity	2.87e-05	0.000915	CcSEcCtD
Amphetamine—Hypertension—Sibutramine—obesity	2.86e-05	0.000911	CcSEcCtD
Amphetamine—Dry mouth—Orlistat—obesity	2.85e-05	0.000908	CcSEcCtD
Amphetamine—Tension—Bupropion—obesity	2.83e-05	0.000903	CcSEcCtD
Amphetamine—Chest pain—Sibutramine—obesity	2.82e-05	0.000899	CcSEcCtD
Amphetamine—Anxiety—Sibutramine—obesity	2.81e-05	0.000896	CcSEcCtD
Amphetamine—CYP2D6—liver—obesity	2.81e-05	0.00361	CbGeAlD
Amphetamine—Nervousness—Bupropion—obesity	2.8e-05	0.000894	CcSEcCtD
Amphetamine—Anaphylactic shock—Orlistat—obesity	2.79e-05	0.00089	CcSEcCtD
Amphetamine—Abdominal pain upper—Topiramate—obesity	2.79e-05	0.000889	CcSEcCtD
Amphetamine—Infection—Orlistat—obesity	2.77e-05	0.000884	CcSEcCtD
Amphetamine—Dry mouth—Sibutramine—obesity	2.76e-05	0.000879	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Topiramate—obesity	2.75e-05	0.000877	CcSEcCtD
Amphetamine—Tremor—Bupropion—obesity	2.7e-05	0.000862	CcSEcCtD
Amphetamine—Anaphylactic shock—Sibutramine—obesity	2.7e-05	0.000861	CcSEcCtD
Amphetamine—Hyperhidrosis—Orlistat—obesity	2.7e-05	0.00086	CcSEcCtD
Amphetamine—Infection—Sibutramine—obesity	2.68e-05	0.000856	CcSEcCtD
Amphetamine—Agitation—Bupropion—obesity	2.65e-05	0.000846	CcSEcCtD
Amphetamine—Angioedema—Bupropion—obesity	2.64e-05	0.000841	CcSEcCtD
Amphetamine—Tachycardia—Sibutramine—obesity	2.64e-05	0.000841	CcSEcCtD
Amphetamine—Hyperhidrosis—Sibutramine—obesity	2.61e-05	0.000833	CcSEcCtD
Amphetamine—Anorexia—Sibutramine—obesity	2.57e-05	0.000821	CcSEcCtD
Amphetamine—Palpitations—Bupropion—obesity	2.55e-05	0.000813	CcSEcCtD
Amphetamine—Insomnia—Orlistat—obesity	2.52e-05	0.000805	CcSEcCtD
Amphetamine—Convulsion—Bupropion—obesity	2.5e-05	0.000797	CcSEcCtD
Amphetamine—Hypertension—Bupropion—obesity	2.49e-05	0.000794	CcSEcCtD
Amphetamine—Dyspepsia—Orlistat—obesity	2.46e-05	0.000784	CcSEcCtD
Amphetamine—Chest pain—Bupropion—obesity	2.46e-05	0.000783	CcSEcCtD
Amphetamine—Anxiety—Bupropion—obesity	2.45e-05	0.000781	CcSEcCtD
Amphetamine—Insomnia—Sibutramine—obesity	2.44e-05	0.000779	CcSEcCtD
Amphetamine—Erectile dysfunction—Topiramate—obesity	2.43e-05	0.000775	CcSEcCtD
Amphetamine—Decreased appetite—Orlistat—obesity	2.43e-05	0.000774	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Orlistat—obesity	2.41e-05	0.000768	CcSEcCtD
Amphetamine—Dyspnoea—Sibutramine—obesity	2.41e-05	0.000768	CcSEcCtD
Amphetamine—Photosensitivity reaction—Topiramate—obesity	2.41e-05	0.000768	CcSEcCtD
Amphetamine—Fatigue—Orlistat—obesity	2.41e-05	0.000767	CcSEcCtD
Amphetamine—Dry mouth—Bupropion—obesity	2.4e-05	0.000766	CcSEcCtD
Amphetamine—Somnolence—Sibutramine—obesity	2.4e-05	0.000766	CcSEcCtD
Amphetamine—Weight decreased—Topiramate—obesity	2.39e-05	0.000761	CcSEcCtD
Amphetamine—Dyspepsia—Sibutramine—obesity	2.38e-05	0.000758	CcSEcCtD
Amphetamine—Anaphylactic shock—Bupropion—obesity	2.35e-05	0.000751	CcSEcCtD
Amphetamine—Decreased appetite—Sibutramine—obesity	2.35e-05	0.000749	CcSEcCtD
Amphetamine—Depression—Topiramate—obesity	2.35e-05	0.000748	CcSEcCtD
Amphetamine—Ephedrine—BCHE—obesity	2.34e-05	0.0332	CrCbGaD
Amphetamine—Infection—Bupropion—obesity	2.34e-05	0.000746	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Topiramate—obesity	2.33e-05	0.000744	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Sibutramine—obesity	2.33e-05	0.000744	CcSEcCtD
Amphetamine—Phenylpropanolamine—DRD1—obesity	2.31e-05	0.0328	CrCbGaD
Amphetamine—Constipation—Sibutramine—obesity	2.31e-05	0.000737	CcSEcCtD
Amphetamine—Tachycardia—Bupropion—obesity	2.3e-05	0.000733	CcSEcCtD
Amphetamine—Urinary tract infection—Topiramate—obesity	2.29e-05	0.000729	CcSEcCtD
Amphetamine—Gastrointestinal pain—Orlistat—obesity	2.28e-05	0.000728	CcSEcCtD
Amphetamine—Hyperhidrosis—Bupropion—obesity	2.28e-05	0.000726	CcSEcCtD
Amphetamine—Anorexia—Bupropion—obesity	2.24e-05	0.000716	CcSEcCtD
Amphetamine—Urticaria—Orlistat—obesity	2.22e-05	0.000707	CcSEcCtD
Amphetamine—Gastrointestinal pain—Sibutramine—obesity	2.21e-05	0.000704	CcSEcCtD
Amphetamine—Body temperature increased—Orlistat—obesity	2.21e-05	0.000704	CcSEcCtD
Amphetamine—Abdominal pain—Orlistat—obesity	2.21e-05	0.000704	CcSEcCtD
Amphetamine—Phenylpropanolamine—ADRB1—obesity	2.15e-05	0.0304	CrCbGaD
Amphetamine—Urticaria—Sibutramine—obesity	2.15e-05	0.000684	CcSEcCtD
Amphetamine—Abdominal pain—Sibutramine—obesity	2.14e-05	0.000681	CcSEcCtD
Amphetamine—Body temperature increased—Sibutramine—obesity	2.14e-05	0.000681	CcSEcCtD
Amphetamine—Insomnia—Bupropion—obesity	2.13e-05	0.000679	CcSEcCtD
Amphetamine—Dyspnoea—Bupropion—obesity	2.1e-05	0.00067	CcSEcCtD
Amphetamine—Somnolence—Bupropion—obesity	2.09e-05	0.000668	CcSEcCtD
Amphetamine—Dyspepsia—Bupropion—obesity	2.07e-05	0.000661	CcSEcCtD
Amphetamine—Hypersensitivity—Orlistat—obesity	2.06e-05	0.000656	CcSEcCtD
Amphetamine—Decreased appetite—Bupropion—obesity	2.05e-05	0.000653	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Bupropion—obesity	2.03e-05	0.000648	CcSEcCtD
Amphetamine—Fatigue—Bupropion—obesity	2.03e-05	0.000647	CcSEcCtD
Amphetamine—Ephedrine—ADRB2—obesity	2.01e-05	0.0285	CrCbGaD
Amphetamine—Constipation—Bupropion—obesity	2.01e-05	0.000642	CcSEcCtD
Amphetamine—Asthenia—Orlistat—obesity	2e-05	0.000639	CcSEcCtD
Amphetamine—Erythema multiforme—Topiramate—obesity	2e-05	0.000637	CcSEcCtD
Amphetamine—Hypersensitivity—Sibutramine—obesity	1.99e-05	0.000635	CcSEcCtD
Amphetamine—Asthenia—Sibutramine—obesity	1.94e-05	0.000618	CcSEcCtD
Amphetamine—Gastrointestinal pain—Bupropion—obesity	1.93e-05	0.000614	CcSEcCtD
Amphetamine—Diarrhoea—Orlistat—obesity	1.91e-05	0.000609	CcSEcCtD
Amphetamine—Urticaria—Bupropion—obesity	1.87e-05	0.000597	CcSEcCtD
Amphetamine—Abdominal pain—Bupropion—obesity	1.86e-05	0.000594	CcSEcCtD
Amphetamine—Body temperature increased—Bupropion—obesity	1.86e-05	0.000594	CcSEcCtD
Amphetamine—Diarrhoea—Sibutramine—obesity	1.85e-05	0.000589	CcSEcCtD
Amphetamine—Dizziness—Orlistat—obesity	1.85e-05	0.000589	CcSEcCtD
Amphetamine—Pseudoephedrine—ADRB1—obesity	1.82e-05	0.0257	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB2—obesity	1.81e-05	0.0256	CrCbGaD
Amphetamine—Tension—Topiramate—obesity	1.8e-05	0.000575	CcSEcCtD
Amphetamine—Dizziness—Sibutramine—obesity	1.79e-05	0.00057	CcSEcCtD
Amphetamine—Nervousness—Topiramate—obesity	1.79e-05	0.000569	CcSEcCtD
Amphetamine—Vomiting—Orlistat—obesity	1.77e-05	0.000566	CcSEcCtD
Amphetamine—Rash—Orlistat—obesity	1.76e-05	0.000561	CcSEcCtD
Amphetamine—Dermatitis—Orlistat—obesity	1.76e-05	0.000561	CcSEcCtD
Amphetamine—Headache—Orlistat—obesity	1.75e-05	0.000558	CcSEcCtD
Amphetamine—Hypersensitivity—Bupropion—obesity	1.73e-05	0.000553	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—obesity	1.72e-05	0.0244	CrCbGaD
Amphetamine—Tremor—Topiramate—obesity	1.72e-05	0.000549	CcSEcCtD
Amphetamine—Vomiting—Sibutramine—obesity	1.72e-05	0.000548	CcSEcCtD
Amphetamine—Rash—Sibutramine—obesity	1.7e-05	0.000543	CcSEcCtD
Amphetamine—Dermatitis—Sibutramine—obesity	1.7e-05	0.000543	CcSEcCtD
Amphetamine—Headache—Sibutramine—obesity	1.69e-05	0.00054	CcSEcCtD
Amphetamine—Nateglinide—PPARG—obesity	1.69e-05	0.0239	CrCbGaD
Amphetamine—Asthenia—Bupropion—obesity	1.69e-05	0.000539	CcSEcCtD
Amphetamine—Agitation—Topiramate—obesity	1.69e-05	0.000539	CcSEcCtD
Amphetamine—Tranylcypromine—CYP2E1—obesity	1.67e-05	0.0237	CrCbGaD
Amphetamine—Nausea—Orlistat—obesity	1.66e-05	0.000529	CcSEcCtD
Amphetamine—Palpitations—Topiramate—obesity	1.62e-05	0.000518	CcSEcCtD
Amphetamine—Diarrhoea—Bupropion—obesity	1.61e-05	0.000514	CcSEcCtD
Amphetamine—Nausea—Sibutramine—obesity	1.6e-05	0.000512	CcSEcCtD
Amphetamine—Convulsion—Topiramate—obesity	1.59e-05	0.000508	CcSEcCtD
Amphetamine—Hypertension—Topiramate—obesity	1.59e-05	0.000506	CcSEcCtD
Amphetamine—Chest pain—Topiramate—obesity	1.56e-05	0.000499	CcSEcCtD
Amphetamine—Anxiety—Topiramate—obesity	1.56e-05	0.000497	CcSEcCtD
Amphetamine—Dizziness—Bupropion—obesity	1.56e-05	0.000497	CcSEcCtD
Amphetamine—Dry mouth—Topiramate—obesity	1.53e-05	0.000488	CcSEcCtD
Amphetamine—Pseudoephedrine—ADRB2—obesity	1.53e-05	0.0216	CrCbGaD
Amphetamine—Vomiting—Bupropion—obesity	1.5e-05	0.000477	CcSEcCtD
Amphetamine—Infection—Topiramate—obesity	1.49e-05	0.000475	CcSEcCtD
Amphetamine—Rash—Bupropion—obesity	1.48e-05	0.000474	CcSEcCtD
Amphetamine—Dermatitis—Bupropion—obesity	1.48e-05	0.000473	CcSEcCtD
Amphetamine—Headache—Bupropion—obesity	1.48e-05	0.00047	CcSEcCtD
Amphetamine—Tachycardia—Topiramate—obesity	1.46e-05	0.000467	CcSEcCtD
Amphetamine—Phentermine—SLC6A4—obesity	1.46e-05	0.0207	CrCbGaD
Amphetamine—Hyperhidrosis—Topiramate—obesity	1.45e-05	0.000463	CcSEcCtD
Amphetamine—Anorexia—Topiramate—obesity	1.43e-05	0.000456	CcSEcCtD
Amphetamine—Nausea—Bupropion—obesity	1.4e-05	0.000446	CcSEcCtD
Amphetamine—Pseudoephedrine—SLC6A4—obesity	1.39e-05	0.0196	CrCbGaD
Amphetamine—Insomnia—Topiramate—obesity	1.36e-05	0.000433	CcSEcCtD
Amphetamine—Benzyl alcohol—CYP2E1—obesity	1.35e-05	0.0191	CrCbGaD
Amphetamine—Dyspnoea—Topiramate—obesity	1.34e-05	0.000427	CcSEcCtD
Amphetamine—Somnolence—Topiramate—obesity	1.33e-05	0.000425	CcSEcCtD
Amphetamine—Dyspepsia—Topiramate—obesity	1.32e-05	0.000421	CcSEcCtD
Amphetamine—Decreased appetite—Topiramate—obesity	1.3e-05	0.000416	CcSEcCtD
Amphetamine—Selegiline—CYP2E1—obesity	1.3e-05	0.0183	CrCbGaD
Amphetamine—Gastrointestinal disorder—Topiramate—obesity	1.3e-05	0.000413	CcSEcCtD
Amphetamine—Fatigue—Topiramate—obesity	1.29e-05	0.000413	CcSEcCtD
Amphetamine—Constipation—Topiramate—obesity	1.28e-05	0.000409	CcSEcCtD
Amphetamine—Gastrointestinal pain—Topiramate—obesity	1.23e-05	0.000391	CcSEcCtD
Amphetamine—Urticaria—Topiramate—obesity	1.19e-05	0.00038	CcSEcCtD
Amphetamine—Abdominal pain—Topiramate—obesity	1.19e-05	0.000378	CcSEcCtD
Amphetamine—Body temperature increased—Topiramate—obesity	1.19e-05	0.000378	CcSEcCtD
Amphetamine—Phenelzine—CYP2E1—obesity	1.14e-05	0.0162	CrCbGaD
Amphetamine—Hypersensitivity—Topiramate—obesity	1.11e-05	0.000353	CcSEcCtD
Amphetamine—Asthenia—Topiramate—obesity	1.08e-05	0.000343	CcSEcCtD
Amphetamine—Methamphetamine—SLC6A4—obesity	1.04e-05	0.0148	CrCbGaD
Amphetamine—Diarrhoea—Topiramate—obesity	1.03e-05	0.000327	CcSEcCtD
Amphetamine—Dizziness—Topiramate—obesity	9.92e-06	0.000316	CcSEcCtD
Amphetamine—Vomiting—Topiramate—obesity	9.54e-06	0.000304	CcSEcCtD
Amphetamine—Rash—Topiramate—obesity	9.46e-06	0.000302	CcSEcCtD
Amphetamine—Dermatitis—Topiramate—obesity	9.45e-06	0.000301	CcSEcCtD
Amphetamine—Headache—Topiramate—obesity	9.4e-06	0.0003	CcSEcCtD
Amphetamine—Nausea—Topiramate—obesity	8.91e-06	0.000284	CcSEcCtD
Amphetamine—Nateglinide—ALB—obesity	6.36e-06	0.00901	CrCbGaD
Amphetamine—SLC22A3—Metabolism—CAV1—obesity	9.93e-07	5.21e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOA1—obesity	9.91e-07	5.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FABP4—obesity	9.88e-07	5.18e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLUL—obesity	9.88e-07	5.18e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—obesity	9.88e-07	5.18e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—obesity	9.86e-07	5.17e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—obesity	9.85e-07	5.16e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKAR2B—obesity	9.64e-07	5.06e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FASN—obesity	9.64e-07	5.05e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—BCHE—obesity	9.6e-07	5.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—obesity	9.59e-07	5.03e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCD—obesity	9.51e-07	4.99e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CD—obesity	9.4e-07	4.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ECHS1—obesity	9.37e-07	4.91e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UCP2—obesity	9.37e-07	4.91e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UCP3—obesity	9.37e-07	4.91e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HSD11B1—obesity	9.37e-07	4.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NCF2—obesity	9.31e-07	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—obesity	9.31e-07	4.88e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—C3—obesity	9.29e-07	4.87e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—obesity	9.28e-07	4.87e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP2E1—obesity	9.26e-07	4.86e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH1B—obesity	9.22e-07	4.83e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NQO1—obesity	9.16e-07	4.8e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACSL1—obesity	9.07e-07	4.76e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1B—obesity	9.07e-07	4.76e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPAM—obesity	9.07e-07	4.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPY—obesity	9.07e-07	4.76e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—obesity	9.05e-07	4.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IAPP—obesity	9.02e-07	4.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOC3—obesity	9.02e-07	4.73e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3R1—obesity	8.88e-07	4.66e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NOS3—obesity	8.88e-07	4.66e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGT—obesity	8.83e-07	4.63e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HADH—obesity	8.81e-07	4.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PCK1—obesity	8.81e-07	4.62e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FADS1—obesity	8.81e-07	4.62e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC2A4—obesity	8.78e-07	4.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCG—obesity	8.78e-07	4.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1B—obesity	8.75e-07	4.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CRH—obesity	8.75e-07	4.59e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—obesity	8.73e-07	4.58e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYCS—obesity	8.66e-07	4.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SDC1—obesity	8.66e-07	4.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCD—obesity	8.64e-07	4.53e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—obesity	8.61e-07	4.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACP5—obesity	8.57e-07	4.49e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INS—obesity	8.57e-07	4.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKR1C3—obesity	8.52e-07	4.47e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—obesity	8.5e-07	4.46e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—obesity	8.5e-07	4.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—obesity	8.45e-07	4.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—C3—obesity	8.44e-07	4.43e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—obesity	8.39e-07	4.4e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NCOA1—obesity	8.37e-07	4.39e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—G6PD—obesity	8.35e-07	4.38e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPS—obesity	8.3e-07	4.35e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—STK11—obesity	8.25e-07	4.33e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP19A1—obesity	8.25e-07	4.33e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF2—obesity	8.25e-07	4.33e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HK1—obesity	8.25e-07	4.33e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CB—obesity	8.2e-07	4.3e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—F2—obesity	8.16e-07	4.28e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCB—obesity	8.16e-07	4.28e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2C—obesity	8.14e-07	4.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD1—obesity	8.14e-07	4.27e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—obesity	8.12e-07	4.26e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—obesity	8.02e-07	4.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPA—obesity	7.97e-07	4.18e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CD—obesity	7.96e-07	4.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK2—obesity	7.92e-07	4.15e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB1—obesity	7.88e-07	4.13e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—obesity	7.85e-07	4.12e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—obesity	7.81e-07	4.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPIN1—obesity	7.8e-07	4.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PARP1—obesity	7.71e-07	4.05e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GHRL—obesity	7.71e-07	4.05e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—COMT—obesity	7.67e-07	4.02e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD4—obesity	7.65e-07	4.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA5—obesity	7.64e-07	4.01e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GNB3—obesity	7.57e-07	3.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARGC1A—obesity	7.57e-07	3.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—HMOX1—obesity	7.53e-07	3.95e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NOS3—obesity	7.51e-07	3.94e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3R1—obesity	7.51e-07	3.94e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—obesity	7.43e-07	3.9e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—obesity	7.43e-07	3.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCB—obesity	7.41e-07	3.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—F2—obesity	7.41e-07	3.89e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GNAS—obesity	7.37e-07	3.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—obesity	7.31e-07	3.83e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC22A1—obesity	7.29e-07	3.82e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CLOCK—obesity	7.29e-07	3.82e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOB—obesity	7.21e-07	3.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TCF7L2—obesity	7.18e-07	3.76e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT2—obesity	7.14e-07	3.75e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SULT2A1—obesity	7.1e-07	3.72e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLP1R—obesity	7.1e-07	3.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—obesity	7.09e-07	3.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTPN1—obesity	7.06e-07	3.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GCG—obesity	7.06e-07	3.7e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—obesity	6.99e-07	3.66e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CB—obesity	6.93e-07	3.64e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—obesity	6.89e-07	3.61e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—obesity	6.87e-07	3.6e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CD—obesity	6.86e-07	3.6e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—obesity	6.85e-07	3.59e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—obesity	6.75e-07	3.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRL—obesity	6.73e-07	3.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRKAR2B—obesity	6.72e-07	3.53e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—obesity	6.72e-07	3.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DCN—obesity	6.68e-07	3.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STK11—obesity	6.63e-07	3.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—obesity	6.6e-07	3.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLG—obesity	6.56e-07	3.44e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—RHOA—obesity	6.55e-07	3.43e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD36—obesity	6.54e-07	3.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1A—obesity	6.49e-07	3.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT2—obesity	6.49e-07	3.4e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3R1—obesity	6.48e-07	3.4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FOXO3—obesity	6.4e-07	3.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—obesity	6.39e-07	3.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NAMPT—obesity	6.37e-07	3.34e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LIPC—obesity	6.33e-07	3.32e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCK—obesity	6.33e-07	3.32e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOC3—obesity	6.29e-07	3.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOCS1—obesity	6.29e-07	3.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CD—obesity	6.23e-07	3.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SOCS3—obesity	6.21e-07	3.26e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—obesity	6.2e-07	3.25e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CETP—obesity	6.11e-07	3.2e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARA—obesity	6.08e-07	3.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNB3—obesity	6.08e-07	3.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SDC1—obesity	6.04e-07	3.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TYK2—obesity	6e-07	3.14e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CB—obesity	5.98e-07	3.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF2—obesity	5.97e-07	3.13e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—RHOA—obesity	5.95e-07	3.12e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKR1C3—obesity	5.94e-07	3.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GNAS—obesity	5.92e-07	3.11e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—obesity	5.89e-07	3.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3R1—obesity	5.89e-07	3.09e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SCARB1—obesity	5.85e-07	3.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOB—obesity	5.8e-07	3.04e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—obesity	5.77e-07	3.03e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAV1—obesity	5.72e-07	3e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOA1—obesity	5.71e-07	2.99e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SREBF1—obesity	5.68e-07	2.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—obesity	5.66e-07	2.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—obesity	5.54e-07	2.9e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—obesity	5.52e-07	2.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FOXO1—obesity	5.5e-07	2.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6KB1—obesity	5.49e-07	2.88e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CB—obesity	5.43e-07	2.85e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FASN—obesity	5.4e-07	2.83e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BCHE—obesity	5.38e-07	2.82e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—obesity	5.21e-07	2.73e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP2E1—obesity	5.19e-07	2.72e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NQO1—obesity	5.13e-07	2.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCD—obesity	5.1e-07	2.68e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—obesity	5.03e-07	2.64e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—obesity	5e-07	2.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—obesity	4.99e-07	2.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—C3—obesity	4.99e-07	2.61e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—obesity	4.96e-07	2.6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INS—obesity	4.93e-07	2.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCG—obesity	4.92e-07	2.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A4—obesity	4.92e-07	2.58e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYCS—obesity	4.86e-07	2.55e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—obesity	4.77e-07	2.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—obesity	4.77e-07	2.5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS2—obesity	4.74e-07	2.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—obesity	4.74e-07	2.48e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NCOA1—obesity	4.7e-07	2.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—obesity	4.64e-07	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—obesity	4.64e-07	2.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP19A1—obesity	4.63e-07	2.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STK11—obesity	4.63e-07	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CAV1—obesity	4.6e-07	2.41e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOA1—obesity	4.59e-07	2.41e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CD—obesity	4.58e-07	2.4e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—obesity	4.52e-07	2.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ESR1—obesity	4.43e-07	2.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—F2—obesity	4.38e-07	2.3e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCB—obesity	4.38e-07	2.3e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3R1—obesity	4.33e-07	2.27e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NOS3—obesity	4.33e-07	2.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BAD—obesity	4.32e-07	2.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COMT—obesity	4.3e-07	2.26e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1A—obesity	4.24e-07	2.22e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GNB3—obesity	4.24e-07	2.22e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—obesity	4.23e-07	2.22e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—HMOX1—obesity	4.22e-07	2.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—obesity	4.19e-07	2.2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IRS1—obesity	4.14e-07	2.17e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GNAS—obesity	4.13e-07	2.17e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—obesity	4.08e-07	2.14e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOB—obesity	4.05e-07	2.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CB—obesity	3.99e-07	2.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—obesity	3.99e-07	2.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—INS—obesity	3.96e-07	2.08e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—obesity	3.96e-07	2.07e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—obesity	3.9e-07	2.05e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—obesity	3.86e-07	2.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—obesity	3.83e-07	2.01e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT2—obesity	3.83e-07	2.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—obesity	3.77e-07	1.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CD—obesity	3.68e-07	1.93e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD36—obesity	3.67e-07	1.92e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—obesity	3.65e-07	1.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—obesity	3.64e-07	1.91e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TYK2—obesity	3.54e-07	1.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RHOA—obesity	3.51e-07	1.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—obesity	3.48e-07	1.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOS3—obesity	3.48e-07	1.82e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3R1—obesity	3.48e-07	1.82e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—obesity	3.45e-07	1.81e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARA—obesity	3.41e-07	1.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—obesity	3.31e-07	1.74e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—obesity	3.3e-07	1.73e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—obesity	3.24e-07	1.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CB—obesity	3.21e-07	1.68e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTOR—obesity	3.21e-07	1.68e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAV1—obesity	3.21e-07	1.68e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOA1—obesity	3.2e-07	1.68e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—obesity	2.98e-07	1.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—obesity	2.93e-07	1.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—obesity	2.92e-07	1.53e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—obesity	2.82e-07	1.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—obesity	2.79e-07	1.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—obesity	2.78e-07	1.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INS—obesity	2.77e-07	1.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK8—obesity	2.71e-07	1.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—obesity	2.71e-07	1.42e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CD—obesity	2.57e-07	1.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—obesity	2.54e-07	1.33e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—obesity	2.48e-07	1.3e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—obesity	2.43e-07	1.28e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3R1—obesity	2.43e-07	1.27e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NOS3—obesity	2.43e-07	1.27e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—obesity	2.3e-07	1.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—obesity	2.3e-07	1.21e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CB—obesity	2.24e-07	1.17e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—obesity	2.22e-07	1.16e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—obesity	1.99e-07	1.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—obesity	1.96e-07	1.03e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—obesity	1.73e-07	9.08e-06	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—obesity	1.6e-07	8.38e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—obesity	1.36e-07	7.16e-06	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—obesity	1.11e-07	5.85e-06	CbGpPWpGaD
